Latest From NeuroTronik Inc.
Device and diagnostics fundraising slumped in Q2, but there was a substantial uptick in M&A activity. Device financings totaled just slightly over half of the previous quarter, while acquisitions grew almost six-fold, thanks primarily to Becton Dickinson's $23.5 billion play for CR Bard. Financing in diagnostics slid to $1.03 billion, less than half of Q1, whereas the $1.7 billion in M&As (most of that from PerkinElmer's $1.3 billion buy of EuroImmun) was more than double Q1's aggregate.
Magenta Medical Ltd, an Israeli start-up founded by cardiology veterans and backed by miniaturized heart pump specialist Abiomed, has reeled in $15m in Series B financing. The additional capital will enable the company to take its catheter-based therapy for acute heart failure through clinical trials and beyond CE-mark approval.
Despite contraction in the number of funds and VC firms investing in life sciences, 2013 was a strong year for private investing in medtech, with private investors putting $2.54 million into 129 medical device deals, according to Informa’s Strategic Transactions. Looking at where investors placed their money revealed some emerging trends.
The North Carolina firm convinced investors to pledge $88 million and layered $50 million in federal small-business loans on top. It has quickly put the funds to work.
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- NeuroTronik Inc.
- Senior Management
Frederick R McCoy, Jr., Pres. & CEO
Steve Masson, CTO & SVP, R&D
- Contact Info
Phone: (919) 883-4155
4021 Stirrup Creek Dr., Ste. 210
Durham, NC 27703-9352
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.